Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research
- 7 May 2016
- journal article
- review article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 51 (1) , 50-72
Abstract
Selective serotonin reuptake inhibitors (SSRIs) have been a mainstay pharmacological treatment for women experiencing depression during pregnancy and postpartum for the past 25 years. SSRIs actviablockade of the presynaptic serotonin transporter and result in a transient increase in synaptic serotonin. Long‐lasting changes in cellular function such as serotonergic transmission, neurogenesis, and epigenetics, are thought to underlie the therapeutic benefits of SSRIs. In recent years, though, growing evidence in clinical and preclinical settings indicate that offspring exposed to SSRIsin uteroor as neonates exhibit long‐lasting behavioral adaptions. Clinically, children exposed to SSRIs in early life exhibit increased internalizing behavior reduced social behavior, and increased risk for depression in adolescence. Similarly, rodents exposed to SSRIs perinatally exhibit increased traits of anxiety‐ or depression‐like behavior. Furthermore, certain individuals appear to be more susceptible to early life SSRI exposure than others, suggesting that perinatal SSRI exposure may pose greater risks for negative outcome within certain populations. Although SSRIs trigger a number of intracellular processes that likely contribute to their therapeutic effects, early life antidepressant exposure during critical neurodevelopmental periods may elicit lasting negative effects in offspring. In this review, we cover the basic development and structure of the serotonin system, how the system is affected by early life SSRI exposure, and the behavioral outcomes of perinatal SSRI exposure in both clinical and preclinical settings. We review recent evidence indicating that perinatal SSRI exposure perturbs the developing limbic system, including altered serotonergic transmission, neurogenesis, and epigenetic processes in the hippocampus, which may contribute to behavioral domains (e.g., sociability, cognition, anxiety, and behavioral despair) that are affected by perinatal SSRI treatment. Identifying the molecular mechanisms that underlie the deleterious behavioral effects of perinatal SSRI exposure may highlight biological mechanisms in the etiology of mood disorders. Moreover, because recent studies suggest that certain individuals may be more susceptible to the negative consequences of early life SSRI exposure than others, understanding mechanisms that drive such susceptibility could lead to individualized treatment strategies for depressed women who are or plan to become pregnant.Keywords
This publication has 349 references indexed in Scilit:
- Electrophysiological and pharmacological properties of GABAergic cells in the dorsal raphe nucleusThe Journal of Physiological Sciences, 2012
- Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strainsPsychopharmacology, 2011
- Neonatal Exposure of Rats to Antidepressants Affects Behavioral Reactions to Novelty and Social Interactions in a Manner Analogous to Autistic Spectrum DisordersThe Anatomical Record, 2011
- Altered Expression of Tyrosine Hydroxylase in the Locus Coeruleus Noradrenergic System in Citalopram Neonatally Exposed Rats and Monoamine Oxidase A Knock Out MiceThe Anatomical Record, 2011
- Early Institutionalization: Neurobiological Consequences and Genetic ModifiersNeuropsychology Review, 2010
- Effects of early life stress on cognitive and affective function: an integrated review of human literaturePsychopharmacology, 2010
- Neonatal Exposure to Citalopram Selectively Alters the Expression of the Serotonin Transporter in the Hippocampus: Dose‐Dependent EffectsThe Anatomical Record, 2010
- Activation of Raphe Efferents to the Medial Prefrontal Cortex by Corticotropin-Releasing Factor: Correlation with Anxiety-Like BehaviorBiological Psychiatry, 2008
- Inter-individual differences in novelty-seeking behavior in rats predict differential responses to desipramine in the forced swim testPsychopharmacology, 2008
- Environmental novelty is signaled by reduction of the hippocampal theta frequencyHippocampus, 2007